Yasmin Leshem

5PUBLICATIONS
3CO-AUTHORS
Cancer therapy (excl. chemotherapy and radiation therapy)Predictive and prognostic markersMolecular targets
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (5)

|Jun 22, 2026
Efficacy and toxicity of neoadjuvant chemotherapy versus chemo-immunotherapy in triple-negative breast cancer patients with and without germline BRCA mutations.

|Jun 10, 2025
In reply to: "Letter to the editor in response to the article:'Squamous cell carcinoma arising in chronically damaged skin (Marjolijn's Ulcer)'".

Mor Miodovnik, Yardenna Dolev, Roni Buchen

|Dec 10, 2024
Squamous cell carcinoma arising in chronically damaged skin (Marjolin's Ulcer): still an unmet need in the era of immunotherapy.

Mor Miodovnik, Yardenna Dolev, Roni Buchen

|Nov 21, 2023
Reply to "Metformin as a booster or obstacle of immunotherapy in patients with non-small cell lung cancer and diabetes mellitus".

Yasmin Leshem, Yardenna Dolev, Nava Siegelmann-Danieli

|Jun 24, 2023
Association between diabetes mellitus and reduced efficacy of pembrolizumab in non-small cell lung cancer.

Yasmin Leshem, Yardenna Dolev, Nava Siegelmann-Danieli

Pageof 1

Frequent Collaborators

2 joint publications

Mor Miodovnik

1 joint publications

Tal Etan

1 joint publications

Shlomit Strulov Shachar